Showing results (101-110 of 1,781) with videos related to

Sort By:
Pageof 179
Dermatology and Therapy|November 28, 2024
Italian Expert Opinion on Chronic Hand Eczema: from Guidelines to Clinical PracticeLuca Stingeni, Maria Concetta Fargnoli, Fabrizio Guarneri, et al.
Dermatology and Therapy|November 27, 2024
Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to CliniciansLarisa Geskin, Christiane Querfeld, Emmilia Hodak, et al.
Dermatology and Therapy|November 12, 2024
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b StudyMelinda Gooderham, Emma Guttman-Yassky, Ken Igawa, et al.
Dermatology and Therapy|October 10, 2024
Regulated Medical Waste Reduction in the Dermatology ClinicDivya K Sharma, Lilia C Murase, Misha Rosenbach, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy|September 19, 2024
A New TGF-β Mimetic, XEP™-716 Miniprotein™, Exhibiting Regenerative Properties Objectivized by Instrumental EvaluationHanane Chajra, Thibaut Saguet, Corinne Granger, et al.
Dermatology and Therapy|September 21, 2024
What's New After NICE Acne GuidelinesAlison M Layton, Girish Gupta, Daron Seukeran, et al.
Dermatology and Therapy|October 28, 2024
Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National SurveyMeredith T Polaskey, Lakshi Aldredge, Candrice Heath, et al.
Dermatology and Therapy|November 8, 2024
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) StudyRichard B Warren, Lev Pavlovsky, Antonio Costanzo, et al.
Dermatology and Therapy|November 2, 2024
Equity and Outcome Events in Hidradenitis Suppurativa: Exploring Effect Modifiers Associated with Diagnostic Delay in the Real WorldNicole Murray, Isabel Truman, Gary Milligan, et al.
Pageof 179